GLYCOPYRRONIUM bromide, 0.2mg/ml, 1ml, amp.
STD
DINJGLYC2A-
Valid Article
Account code:
60000
HS Code:
300490
Last Updated on:
11/12/2024, 19:04:53
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
A03AB02
Anatomical Therapeutic Chemical Classification according to WHOCC
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
GLYCOPYRRONIUM bromide
- Not in the WHO list of Essential Medicines 2023
Therapeutic Action
Antisialogogue (agent that decreases production of saliva)
Indications
Glycopyrrolate is a synthetic anticholinergic agent used in anaesthesia.
Some restricted information has been hidden. Sign in
to see this information
Instructions for use
Pre-anaesthetic and intraoperative use:
- Adults: 0.2 mg to 0.4 mg by IV or IM route
- Children (1 month to 12 years of age): 0.004 to 0.008 mg/kg to a maximum of 0.2 mg by IV or IM route
Reversal of neuromuscular blockade:
- Adults: 0.2 mg per 1 mg neostigmine by IV route. Alternatively, a dose of 0.01-0.015 mg by IV route with 0.05 mg/kg neostigmine
- Children (1 month to 12 years of age): 0.01 mg/kg by IV route with 0.05 mg/kg neostigmine
Precautions for Use
Toxicity due to over dosage or administration of excessive dose.
Toxicity will be mitigated/prevented by ensuring administration of proper dose, the drug should only be administered by a health professional.
Storage
Below 25ºC - Protect from sunlight